OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Remdesivir: A Review in COVID-19
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 13, pp. 1215-1237
Open Access | Times Cited: 35
Hannah A. Blair
Drugs (2023) Vol. 83, Iss. 13, pp. 1215-1237
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Electrochemical protein biosensors for disease marker detection: progress and opportunities
Lanpeng Guo, Yunong Zhao, Qing Huang, et al.
Microsystems & Nanoengineering (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Lanpeng Guo, Yunong Zhao, Qing Huang, et al.
Microsystems & Nanoengineering (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Clinical trials and their impact on policy during COVID-19: a review
Paul Glasziou, Sharon Sanders, Oyungerel Byambasuren, et al.
Wellcome Open Research (2024) Vol. 9, pp. 20-20
Open Access | Times Cited: 9
Paul Glasziou, Sharon Sanders, Oyungerel Byambasuren, et al.
Wellcome Open Research (2024) Vol. 9, pp. 20-20
Open Access | Times Cited: 9
Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival
Sabrina Mendes, Lays Cordeiro Guimarães, Leonardo Camilo de Oliveira, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 558-573
Closed Access | Times Cited: 1
Sabrina Mendes, Lays Cordeiro Guimarães, Leonardo Camilo de Oliveira, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 558-573
Closed Access | Times Cited: 1
Repurposing expired Remdesivir as a sustainable anti-corrosion agent for plain steel in HCl medium: Insights from electrochemical and molecular dynamics studies
Ismat H. Ali, Ruhollah Sharifi, Ali Asghar Javidparvar, et al.
Journal of Industrial and Engineering Chemistry (2025)
Open Access | Times Cited: 1
Ismat H. Ali, Ruhollah Sharifi, Ali Asghar Javidparvar, et al.
Journal of Industrial and Engineering Chemistry (2025)
Open Access | Times Cited: 1
Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review
Hadi Al-Jamal, Sara Idriss, Rabih Roufayel, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 320-320
Open Access | Times Cited: 7
Hadi Al-Jamal, Sara Idriss, Rabih Roufayel, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 320-320
Open Access | Times Cited: 7
Differences in biomarker levels and proteomic survival prediction across two COVID-19 cohorts with distinct treatments
Cecilie Bo Hansen, Maria Elizabeth Engel Møller, Laura Pérez‐Alós, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112046-112046
Open Access
Cecilie Bo Hansen, Maria Elizabeth Engel Møller, Laura Pérez‐Alós, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112046-112046
Open Access
Efficacy and Safety of Sotrovimab Versus Oral Antiviral for Early Treatment in High-Risk Patients in Omicron Era: A Multicenter Retrospective Study
Antonio Russo, Mariantonietta Pisaturo, Chiara Cacace, et al.
Pathogens (2025) Vol. 14, Iss. 3, pp. 216-216
Open Access
Antonio Russo, Mariantonietta Pisaturo, Chiara Cacace, et al.
Pathogens (2025) Vol. 14, Iss. 3, pp. 216-216
Open Access
Research Note: Antiviral effect of remdesivir against experimental Newcastle disease virus infection in chickens
Hiewa Othman Dyary
Poultry Science (2025), pp. 105022-105022
Open Access
Hiewa Othman Dyary
Poultry Science (2025), pp. 105022-105022
Open Access
Impact of remdesivir on liver function: A comparative study of diabetic and non-diabetic COVID-19 patients
Zabiholah Zarei, Elham Nejadsadeghi, Seyedeh Leila Dehghani, et al.
Endocrine and Metabolic Science (2025), pp. 100237-100237
Open Access
Zabiholah Zarei, Elham Nejadsadeghi, Seyedeh Leila Dehghani, et al.
Endocrine and Metabolic Science (2025), pp. 100237-100237
Open Access
Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs
Shin Aoki, Tomohiro Tanaka, Kenta Yokoi, et al.
Chemical and Pharmaceutical Bulletin (2025) Vol. 73, Iss. 4, pp. 355-368
Open Access
Shin Aoki, Tomohiro Tanaka, Kenta Yokoi, et al.
Chemical and Pharmaceutical Bulletin (2025) Vol. 73, Iss. 4, pp. 355-368
Open Access
Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment
Peisen Zheng, Guanguan Li, Yuanguang Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130243-130243
Closed Access
Peisen Zheng, Guanguan Li, Yuanguang Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130243-130243
Closed Access
Vigilant biosecurity in the post-COVID-19 era: implications for biological warfare preparedness
Ahmad Reza Rezaei
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Ahmad Reza Rezaei
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Long‐COVID in children and their parents: A prospective cohort study
Hiroyuki Iijima, Takanori Funaki, M. Kubota
Pediatrics International (2025) Vol. 67, Iss. 1
Open Access
Hiroyuki Iijima, Takanori Funaki, M. Kubota
Pediatrics International (2025) Vol. 67, Iss. 1
Open Access
Characterizing Public Sentiments and Drug Interactions during COVID-19: A Pretrained Language Model and Network Analysis of Social Media Discourse
Wanxin Li, Yining Hua, Peilin Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Wanxin Li, Yining Hua, Peilin Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections
Selwyn J. Hurwitz, Ramyani De, Julia C. LeCher, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 651-651
Open Access | Times Cited: 2
Selwyn J. Hurwitz, Ramyani De, Julia C. LeCher, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 651-651
Open Access | Times Cited: 2
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
Inclusion Complexation of Remdesivir with Cyclodextrins: A Comprehensive Review on Combating Coronavirus Resistance—Current State and Future Perspectives
Arumugam Anitha, Rajaram Rajamohan, Moorthiraman Murugan, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4782-4782
Open Access | Times Cited: 1
Arumugam Anitha, Rajaram Rajamohan, Moorthiraman Murugan, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4782-4782
Open Access | Times Cited: 1
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
Intranasal liposomal angiotensin-(1-7) administration reduces inflammation and viral load in the lungs during SARS-CoV-2 infection in K18-hACE2 transgenic mice
Sabrina Mendes, Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 1
Sabrina Mendes, Lays Cordeiro Guimarães, Pedro Augusto Carvalho Costa, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 1
Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese population
Cristiana P. Von Rekowski, Iola Pinto, Tiago A. H. Fonseca, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Cristiana P. Von Rekowski, Iola Pinto, Tiago A. H. Fonseca, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Advances and Challenges in Antiviral Development for Respiratory Viruses
Luis Adrián De Jesús‐González, Moisés León‐Juárez, Flor Itzel Lira-Hernández, et al.
Pathogens (2024) Vol. 14, Iss. 1, pp. 20-20
Open Access | Times Cited: 1
Luis Adrián De Jesús‐González, Moisés León‐Juárez, Flor Itzel Lira-Hernández, et al.
Pathogens (2024) Vol. 14, Iss. 1, pp. 20-20
Open Access | Times Cited: 1
Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study
Ahmed Khalil, Asmaa Mohamed, Manasik Hassan, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 949-958
Open Access | Times Cited: 3
Ahmed Khalil, Asmaa Mohamed, Manasik Hassan, et al.
Therapeutics and Clinical Risk Management (2023) Vol. Volume 19, pp. 949-958
Open Access | Times Cited: 3
Model for predicting risk of developing drug-induced liver injury during remdesivir therapy: observational prospective open case-control study
Yu. V. Shevchuk, А. V. Kryukov, И. И. Темирбулатов, et al.
Pharmacy & Pharmacology (2023) Vol. 11, Iss. 3, pp. 228-239
Open Access | Times Cited: 1
Yu. V. Shevchuk, А. V. Kryukov, И. И. Темирбулатов, et al.
Pharmacy & Pharmacology (2023) Vol. 11, Iss. 3, pp. 228-239
Open Access | Times Cited: 1
COMPLICACIONES DE LA VACUNA CHADOX1 EN PACIENTES CON ENFERMEDADES CARDIOVASCULARES: REVISIÓN BIBLIOGRÁFICA.
Darwin Daniel Campos González, Carlos Alberto Chacón Sánchez, Gloria Anabel Ortíz Cruz, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 2, pp. 2-12
Open Access
Darwin Daniel Campos González, Carlos Alberto Chacón Sánchez, Gloria Anabel Ortíz Cruz, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 2, pp. 2-12
Open Access
The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations
Riccardo Melis, Angela Braca, Daniela Pagnozzi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Riccardo Melis, Angela Braca, Daniela Pagnozzi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
